Carmenta Bioscience

Carmenta Bioscience, Inc. is a private medical technology company dedicated to improving maternal and infant health. Carmenta Bioscience, which spun off from Stanford University School of Medicine in 2012, is currently developing a highly accurate, serum-based preeclampsia diagnostic test.